A blueprint for pharmacy benefit managers to increase value
- PMID: 19284805
- PMCID: PMC2737824
A blueprint for pharmacy benefit managers to increase value
Abstract
Pharmacy benefit managers (PBMs) have a unique opportunity to promote health and generate value in the healthcare system. Today, PBMs are largely evaluated on their ability to control costs rather than improve health. Pharmacy benefit managers should be evaluated along 3 dimensions in which they can increase value: (1) use of cost-effective medications, (2) timely initiation of appropriate medication therapy, and (3) adherence to that therapy. Value creation requires the development of integrated data systems, stronger partnerships with patients and physicians, and improved measurement and reporting of results. Incentives for PBMs to promote value should drive innovation and improve health outcomes.
Conflict of interest statement
References
-
- Porter ME, Teisberg EO. Redesigning Healthcare: Creating Value-Based Competition in Results. Boston, MA: Harvard Business School Press; 2006.
-
- Atlas RF. The role of PBMs in implementing the Medicare prescription drug benefit. Health Aff (Millwood) 2004:W4504–W4515. Suppl Web Exclusives. - PubMed
-
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. - PubMed
-
- Shrank WH, Asch SM, Adams J, et al. The quality of pharmacologic care for adults in the United States. Med Care. 2006;44(10):936–945. - PubMed
-
- National Council on Patient Information and Education. Enhancing Prescription Medicine Adherence: A National Action Plan. 2007. Aug [Accessed May 12, 2008]. http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adh....